期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠心病患者冠状动脉病变严重程度与冠心病危险因素的相关分析 被引量：5

下载PDF
导出
摘要 目的探讨冠心病患者冠状动脉病变严重程度与冠心病危险因素的相关性,为临床治疗和预防该病提供相关参考。方法随机选取于2012年9月至2013年12月间我院相关科室收治确诊为冠心病的患者279例,对所有患者包括患者年龄、BMI水平、吸烟情况、有无糖尿病史、有无家族病史等进行调查,实时监测患者血压、血脂变化情况,对患者BMI水平进行评测,统计并分析相关数据。结果选取的冠心病患者冠状动脉病变严重程度,与年龄、血脂水平、BMI水平、吸烟情况、糖尿病患病经历、家族遗传等因素都呈现较高的相关性(P<0.05)。结论在有关预防、治疗、后期护理冠心病冠状动脉病变的过程中可从多种发病因素开展,加强对该病症的控制,值得临床广泛研究和借鉴。
作者 覃双林
机构地区 四川省南充市高坪区中医医院
出处 《心血管病防治知识（学术版）》 2014年第11期57-59,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 冠心病 冠状动脉病变 相关分析
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

二级参考文献26

  • 1汪海娅,高平进,姬开达,沈卫峰,陆林,朱鼎良.稳定性冠心病患者循环内皮祖细胞与冠状动脉病变严重程度的分析[J].中华心血管病杂志,2005,33(5):425-427. 被引量：13
  • 2陆国平,吴志俊,戚文航.他汀类药物与动脉粥样硬化斑块消退[J].中国循环杂志,2007,22(1):69-72. 被引量：25
  • 3Ford ES,Ajani UA,Croft JB,et al. Explaining the decrease in U. S.deaths from coronary disease, 1980-2000. N Engl J Med, 2007,356 ( 23 ) :2388-2398.
  • 4Morgan TM, Krumholz HM, Lifton RP, et al. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale repli- cation study. JAMA,2007,297(14) :1551-1561.
  • 5Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case-control study. Lancet,2004,364 ( 9438 ) : 937-952.
  • 6Clendenning R. The optimal low-density lipoprotein is 50 to 70 mg/dl [ letter. J Am Coll Cardio1,2005,45 (10) : 1732.
  • 7Reardon MF, Nestel PJ, Craig IH, et al. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation, 1985,71 (5) :881-888.
  • 8Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J, 1990, 119: 1262-1267.
  • 9Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases,part I general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001,104 ( 22 ) : 2746-2753.
  • 10Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults( Adult Treatment Panel III). JAMA ,2001,285 ( 19 ) :2486-2497.

共引文献307

同被引文献23

  • 1Kimura S,Inagaki H, Haraguchi G, et al. Relationships of elevated systemic pentraxin-3 levels with high-risk coro- nary plaque components and impaired myocardial perfu- sion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction [ J ]. Circ J,2014,78 ( 1 ) : 159-169.
  • 2Gupta MD, Girish MP, Subhendu MS, et al. Percutaneous coronary intervention of all three coronary arteries origina- ting from single coronary artery arising from the right si- nus [ J ]. C ardiovasc Interv Ther, 2013,28 ( 3 ) :322-326.
  • 3Balin M, Celik A, Kobat MA, et al. Circulating soluble lectin-like oxidized low-density lipoprotein receptor,l lev- els predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients un- dergoing elective native single-vessel PCI [ J ]. J Thromb Thrombolysis,2012,34(4) :483-490.
  • 4Ndrepepa G,Tada T, Fnsaro M, et al. Association of coro- nary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary ar- tery disease [ J ]. Clin Res Cardiol, 2012, 101 ( 12 ) : 1003-1011.
  • 5Higuchi Y, Hiro T, Takayama T, et al. Impact of coronary plaque burden and composition on periprocedural myocar- dial infarction and coronary flow reserve after percutane- ous coronary intervention[ J ]. Int Heart J, 2014,55 ( 5 ) : 391-396.
  • 6Akdeniz C, Umman S, Kaplan A, et al. Coronary plaque composition and post-PCI complications in NSTEMI [ J ]. JACC Cardiovasc Imaa'in.2013.6(12) .1349-1350.
  • 7Sato T, Kameyama T, Noto T, et al. Impaired macrophage production of anti-atherosclerotic interleukin-10 induced by coronary intraplaque hemorrhage in patients with acute coronary syndrome and hyperglycemia [ J ]. J Diabetes Complications, 2014,28 ( 2 ) : 196-202.
  • 8Tanindi A, Sahinarslan A, Elbeg S, et al. Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tis- sue inhibitor of matrix metalloproteinase-1, and interleu- kin-6 with epicardial and myocardial perfusion [ J ]. Coron Artery Dis,2011,22(4) :253-258.
  • 9Robertson L, Grip L, Mattsson HL, et al. Release of pro- tein as well as activity of MMP-9 from unstable athero- sclerotic plaques during percutaneous coronary interven- tion[ J]. J Intern Med,2007,262(6) :659-667.
  • 10张新娅,韩雅玲,荆全民,王效增,李毅,鄢高亮,张磊,霍勇,张岩.老年冠心病患者心血管病危险因素与冠状动脉病变程度的相关性分析[J].解放军医学杂志,2011,36(4):340-343. 被引量：64

引证文献5

二级引证文献36

心血管病防治知识（学术版）
2014年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部